Skip to Content

Division of Pediatrics - Division Priority List

MD Anderson

Pediatric Clinical Trials

  

Disease Type Phase / Type Title Physician Contact / Phone Protocol Number
phase i / new agent program - Solid Tumors (non CNS)  Central Nervous System (CNS)
phase i / new agent program - Solid Tumors (non CNS)  Leukemia
phase i / new agent program - Solid Tumors (non CNS)  Lymphoma
phase i / new agent program - Solid Tumors (non CNS)  Melanoma
phase i / new agent program - Solid Tumors (non CNS)  Neuroblastoma
phase i / new agent program - Solid Tumors (non CNS)  Solid Tumors (non CNS)
   I A Phase I Study to Evaluate the Safety and Pharmacokinetics of Panitumumab in Children with Solid Tumors Hughes, Dennis, M.D., Ph.D. Mote, Estella
(713) 792-4781
2007-0615
   I A Phase I Dose Escalation Study of Cabazitaxel in Pediatric Patients with Refractory Solid Tumors including Tumors of the Central Nervous System Herzog, Cynthia E., M.D. Mote, Estella
(713) 792-4781
2012-0822
Other Divisions' Protocols
   I A Phase I Study of Hepatic Arterial Infusion of Oxaliplatin in Combination With Systemic Fluorouracil, Leucovorin and Bevacizumab With or Without Cetuximab by K-RAS Mutational Status and Liver Function for Patients with Advanced Cancers Metastatic to the Liver. Tsimberidou, Apostolia Maria, M.D., Ph.D. Herzog, Cynthia E., M.D.
(713) 745-0157
2009-0023
   I A Phase I Trial of Doxil, Bevacizumab and Temsirolimus Karp, Daniel D. Main Switchboard
(713) 792-6161
2008-0384
   I A Phase I Trial of Sirolimus and Cetuximab in Patients with Advanced Malignancies Janku, Filip Main Switchboard
(713) 792-6161
2009-0226
   I A multi-arm Phase I trial of hepatic arterial infusion of irinotecan with 1) systemic bevacizumab and cetuximab 2) systemic bevacizumab and oxaliplatin 3) systemic bevacizumab in patients with advanced solid tumors metastatic to the liver Tsimberidou, Apostolia Maria, M.D., Ph.D. Main Switchboard
(713) 792-6161
2009-0410